Skip to main content

Hämorheologische Veränderungen bei Früh- und Mangelgeburten: Bedeutung für die Indikation der Tokolysetherapie

  • Chapter
Standortbestimmung der Tokolysebehandlung
  • 14 Accesses

Zusammenfassung

Das Newtonsche Gesetz der Viskosität besagt, daß Schergeschwindigkeit und Schubspannung des Blutes einander proportional sind. Unter Schubspannung versteht man die Kraft, die das Blut in Form von Flüssigkeitslamellen bewegt und unter Schergeschwindigkeit die Schnelligkeit, in der diese Verschiebung stattfindet. Die Blutviskosität ist somit keine konstante Größe, sondern hängt von verschiedenen Fließbedingungen und Einflußgrößen ab (Abb. 1).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 49.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 59.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Aarts PAMM, Banga JD, v Houwelingen HC, Heethaar RM, Sixma JJ (1984) Increased red blood cell deformability due to Isoxsuprine administration decreases platelet adherence in a perfusion chamber: A double blind cross over study in patients with intermittent Claudication. Blood 67: 1474–1481

    Google Scholar 

  2. Allen JE, Rasmussen H (1971) Human red blood cells: Prostaglandin E2, Epinephrine and Isoproterenol alter deformability. Science 174: 512–514

    Google Scholar 

  3. Buchan PC (1984) Maternal and fetal blood viscosity throughout normal pregnancy. J Obstet Gynecol 4: 143–150

    Article  Google Scholar 

  4. Boß EGH (1987) Der Einfluß der Betamimetika auf die Fließfähigkeit des Blutes. Inaugural-Dissertation, Essen

    Google Scholar 

  5. Cunningham FG, Lowe Th, Guss St, Mason R (1987) Erythrocyte morphology in women with severe preeclampsia and eclampsia. Am J Obstet Gynec 153: 358–363

    Google Scholar 

  6. Ernst E (1986) Hämorheologie für die Praktiker. W Zuckschwerdt, München/Bern/VVien

    Google Scholar 

  7. Garn SM, Ridella SA, Petzold AS, Falkner F (1981) Maternal Hematologic Levels and Pregnancy Outcomes. Seminars in Perinat 5: 155–162

    CAS  Google Scholar 

  8. Heilmann L (1983) Mikrozirkulationsstörungen bei der Gestose. In: Kaulhausen H, Schneider J (Hrsg) Schwangerschaftsbedingte Hypertonie. Thieme, Stuttgart/New York S 63–72

    Google Scholar 

  9. Heilmann L (1987) Blood rheology and pregnancy. Bailliere’s Clin Haematol 1: 777–799

    Article  PubMed  CAS  Google Scholar 

  10. Heilmann L, Buchan PC (eds) (1984) Hemorheological disorders in obstetrics and neonatology. Schattauer, Stuttgart/New York

    Google Scholar 

  11. Heilmann L, Siekmann U (1984) Effects of betamimetics on the erythrocyte deformability: Results in pregnancy. In/ Heilmann L, Buchan PC (eds) Hemorheological disorders in obstetrics and neonatology. Schattauer, Stuttgart/New York

    Google Scholar 

  12. Heilmann L, Hojnacki B, v Tempelhoff GF (1992) Die Hämodilution in der Schwangerschaft zur Verhütung der Plazentainsuffizienz. Med Welt 43: 762–766

    Google Scholar 

  13. Heilmann L, Hojnacki B, Herrle B, v. Tempelhoff GF, Kriechbaum A (1993) Das Hämoglobin — ein geburtshilflicher Risikofaktor. Gebh Frauenk 53: 235–239

    Article  CAS  Google Scholar 

  14. Heilmann L, Hojnacki B, v Tempelhoff GF (1994) Red cell deformability in Gestational Hypertension. Gynec Obstet 37: 155–159

    CAS  Google Scholar 

  15. Hemminki E, Rimpelä U (1991) Iron supplementation, maternal packed cell volume and fetal growth. Arch Dis Childhood 66: 422–425

    Article  CAS  Google Scholar 

  16. Huisman A (1986) Haemorheological Changes during Pregnancy. Thesis, Groningen

    Google Scholar 

  17. Johnston CC, Dowers SL, Urbansi RJ (1977) Examination of the filterability of oxygenated erythrocytes in the presence of L-epinephrine, DL-Isoproterenol or prostaglandins, Prostaglandins 13: 281–295

    Article  PubMed  CAS  Google Scholar 

  18. Knottnerus JA, Delgado LR, Knipschild PG, Essed GGM, Smiths F (1990) Haematologic parameters and pregnancy outcome. J Clin Epidemiol 43: 461–466

    Article  PubMed  CAS  Google Scholar 

  19. Mau G (1977) Hemoglobin changes during pregnancy and growth disturbances in the neonate. J Perinat Med 5: 172–177

    Article  PubMed  CAS  Google Scholar 

  20. Miller KW, Keith JC (1988) Erythrocyte morphologic features and serum chemistry studies in ovine pregnancy-induced hypertension treated with thromboxane synthetase inhibitors. Am J Obstet Gynec 159: 1241–1246

    PubMed  CAS  Google Scholar 

  21. Moll W (1975) Discussions. In: Brosens JA, Dixon G, Robertson WB (eds) Human placentation, Excerpta Medica, Amsterdam. Proceedings of an International Symposium Human Placentation, Leuven

    Google Scholar 

  22. Morbidity and Mortality Weekly Report (1989): CDC criteria for anemia in children and childbearing-aged women. No 38: 400–404

    Google Scholar 

  23. Murphy JF, O’Riordan J, Newsome RG, Coles EC, Pearson JF (1986) Relation of haemoglobin levels in first and second trimester to outcome of pregnancy. Lancet 1: 992–995

    Article  PubMed  CAS  Google Scholar 

  24. Naeye RL, Tafari N (1985) Risk factors in pregnancy and diseases of the fetus and newborn. Williams & Wilkins, Baltimore/London

    Google Scholar 

  25. Peeters LLH, Buchan PC (1989) Blood viscosity in Perinatology. Rev Perinat Med 6: 53–89

    Google Scholar 

  26. Pfafferott C, Volger E, Meiselman HJ (1986) Effect of norepinephrine (NE) and isoprenaline ( IP) on RBC microrheologic behavior. Biorheology 23: 287

    Google Scholar 

  27. Pfafferott C, Brinster G, Kraus L, Volger E (1987) Veränderungen der Erythrozyten-Filtrierbarkeit unter der Wirkung eines Betasympathikomimetikums and eines Betarezeptoren-Antagonisten. In: Strauer BE, Ehrly AM, Leschke M (Hrsg) Fortschritte in der kardiovaskulären Hämorheologie. MWP München

    Google Scholar 

  28. Sager G, Jacobsen S (1979) Plasma dependent adrenergic ligand binding to human erythrocytes. Biochem Pharmacol 28: 2167–2173

    Article  PubMed  CAS  Google Scholar 

  29. Sager G, Jacobsen S (1982) Betaadrenergic ligand binding to receptors on human erythrocytes and lymphocytes. Therapie 37: 629–634

    PubMed  CAS  Google Scholar 

  30. Sager G (1982) Receptor binding sites for beta-adrenergic ligands on human erythrocytes. Biochem Pharmacol 31: 99–104

    Article  PubMed  CAS  Google Scholar 

  31. Samuels Ph, Main EK, Tunutti MT, Gatte SG (1987) The origin of increased serum iron in pregnancy induced hypertension. Am J Obstet Gynec 157: 712–725

    Google Scholar 

  32. Steel SA, Pearce JMF, Nash G, Christopher B, Dormandy J, Bland JM (1988) Maternal blood viscosity and uteroplacental blood flow velocity waveforms in normal and complicated pregnancies. Brit J Obstet Gynec 95: 747–752

    Article  CAS  Google Scholar 

  33. Suda T, Shimizu D, Madea N, Shiga T (1981) Decreased viscosity of human erythrocyte suspension induced by chlorpromazine and isoxsuprine. Biochem Pharmacol 30: 2057–2064

    Article  PubMed  CAS  Google Scholar 

  34. Williams MD, Wheby MS (1992) Anemia in pregnancy. The Med Clinics of North America 76: 631–647

    Google Scholar 

  35. Worley RJ, Hentschel WM, Cormier C, Nutting S, Pead G, Zelenkov K, Smith JB, Ash KO, Williams RR (1982) Increased sodium-lithium countertransport in erythrocytes in pregnant women. New Engl J Med 307: 412–416

    Article  PubMed  CAS  Google Scholar 

  36. Wulf KH (1977) Potential of betamimetic therapy in placental insufficiency. In: Weidinger H (ed) Labour Inhibition by Betamimetic drugs in Obstetrics. Fischer, Stuttgart

    Google Scholar 

  37. Zondervan HA (1988) Blood viscosity in complicated pregnancy. Thesis, Amsterdam

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1994 Dr. Dietrich Steinkopff Verlag, GmbH & Co. KG, Darmstadt

About this chapter

Cite this chapter

Heilmann, L. (1994). Hämorheologische Veränderungen bei Früh- und Mangelgeburten: Bedeutung für die Indikation der Tokolysetherapie. In: Wolff, F. (eds) Standortbestimmung der Tokolysebehandlung. Steinkopff. https://doi.org/10.1007/978-3-642-85429-3_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-85429-3_4

  • Publisher Name: Steinkopff

  • Print ISBN: 978-3-7985-0997-9

  • Online ISBN: 978-3-642-85429-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics